Last update: March 22, 2018
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
9α-Fluoro-16β-methylprednisolone is also known as Betamethasone. Here it is a list of alternative known names::
9α-Fluoro-16β-methylprednisolone in other languages or writings:
9α-Fluoro-16β-methylprednisolone belongs to this group or family:
Main tradenames from several countries containing 9α-Fluoro-16β-methylprednisolone in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 100 | % |
Molecular weight | 393 | daltons |
Protein Binding | 64 | % |
Tmax | 0,2 - 0,5 | hours |
T1/2 | 5,6 | hours |
Write to us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Because pharmacokinetic data suggest excretion into breast milk in significant levels long lasting treatments should use other steroidal drugs known to be excreted in low amounts.
When administered before delivery it may induce delay in phase II of Lactogenesis (coming-in) and a decrease of milk production within the first week post-partum.
Large intra-articular doses may transitory decrease milk production.
WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.